Arcadia Biosciences, Inc. (RKDA)
Nasdaq: RKDA · Crude Petroleum & Natural Gas · Dallas, TX · filing with the SEC since 2009
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
| Report filed | Mar 26, 2026 | Mar 25, 2025 | Mar 28, 2024 | Mar 30, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 25, 2020 | Apr 1, 2019 | Mar 20, 2018 | Mar 8, 2017 |
| Revenue | 4,858 | 5,045 | 4,454r | 7,418r | 6,780 | 8,034 | 1,169 | 1,464 | 4,026 | 3,188 |
| For lenders | ||||||||||
| Net interest income | 221 | 782 | 695 | 289 | -20 | · | · | · | · | · |
| Cost of revenue | 3,098 | 2,963 | 2,174r | 6,101r | 8,708 | 5,199 | · | · | 283 | 895 |
| Research and development | 9 | 53 | 64r | 1,509 | 3,889 | 7,960 | 7,098 | 6,069 | 7,407 | 8,663 |
| Selling, general and administrative | 7,001 | 9,641 | 8,234r | 15,036r | 22,938 | 16,467 | 13,567 | 11,604 | 10,651 | 12,250 |
| Total operating expenses | · | · | · | · | · | 20,812 | 20,550 | 18,334 | 18,341 | 21,808 |
| Total costs and expenses | 7,358 | 8,693 | 10,556r | 21,425r | 42,306 | 20,812 | · | · | · | · |
| Operating income | -2,500 | -3,648 | -6,102r | -14,007r | -35,526 | -12,778 | -19,381 | -16,870 | -14,315 | -18,620 |
| Interest expense | · | · | · | · | 20 | 47 | 5 | · | 747 | 1,319 |
| Other income (expense), net | 2,309 | 31 | 48 | 9r | 10,114 | 740 | 466 | 394 | 281 | 340 |
| Income before income taxes | -2,331 | -4,309 | -5,321r | -10,814r | -16,132 | -6,150 | -28,871 | -13,470 | -15,681 | -19,599 |
| Income tax expense | 8 | 8 | 8 | 14 | 2 | -124 | 2 | 10 | 26 | 25 |
| Income from continuing operations | -2,339 | -4,317 | -5,329r | -10,828 | · | · | · | · | · | · |
| Income from discontinued operations | · | · | -821 | -4,784 | · | · | · | · | · | · |
| Net income including non-controlling interests | -2,339 | -7,038 | -13,986 | -15,612 | -16,134 | -6,026 | -28,873 | -13,480 | · | · |
| Net income to non-controlling interests | · | 0 | -5 | -236 | -1,474 | -1,371 | -68 | · | · | · |
| Net income | -2,339 | -7,038 | -13,981 | -15,376 | -14,660 | -4,655 | -28,805 | -13,480 | -15,707 | -19,624 |
| Net income to common shareholders | · | · | · | · | · | · | · | · | · | -19,624 |
| Earnings per share, basic | -1.71 | -5.17 | -11.29 | -25.65 | -27.56 | · | · | · | · | · |
| Earnings per share, diluted | -1.71 | -5.17 | -11.29 | -25.65 | -27.56 | · | · | · | · | · |
| Earnings per share, basic and diluted | · | · | · | · | -0.69 | -0.47 | -4.53 | -3.58 | -7.28 | -8.85r |
| Weighted average shares, basic | 1,368,057 | 1,363,303 | 1,236,934 | 599,389 | 532,016 | · | · | · | · | · |
| Weighted average shares, diluted | 1,368,057 | 1,363,303 | 1,236,934 | 599,389 | 532,016 | · | · | · | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 21,280,620 | 9,959,018 | 6,363,112 | 3,766,419 | 2,156,201 | 2,218,341r |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:SalesRevenueNetNet interest income interest earned less interest paid
us-gaap:InterestIncomeExpenseNetCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfGoodsSoldResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesTotal costs and expenses every operating cost, the cost of revenue included
us-gaap:CostsAndExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitIncome from continuing operations profit from the businesses it keeps
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestIncome from discontinued operations profit or loss from businesses it sold or closed
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income to non-controlling interests the share that belongs to minority holders
us-gaap:NetIncomeLossAttributableToNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted